ANKIE MARIE AMOS

Allopathic & Osteopathic Physicians|Internal Medicine|Advanced Heart Failure and Transplant Cardiology DENVER, CO NPI 1912911017

General Payments — all program years on this page

$2,499.39

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 84
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $607.57 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $607.5718

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $319.4214
2019 $214.614
2020 $85.952
2021 $552.1616
2022 $233.4112
2023 $486.2718
2024 $607.5718

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077947200 Janssen Pharmaceuticals, Inc $17.54 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080565521 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $139.00 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1081719615 Lexicon Pharmaceuticals, Inc. $17.22 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086225524 Bayer Healthcare Pharmaceuticals Inc. $19.33 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086228154 Bayer Healthcare Pharmaceuticals Inc. $120.38 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086745445 Novartis Pharmaceuticals Corporation $26.57 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101269409 E.R. Squibb & Sons, L.L.C. $25.84 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104206975 AstraZeneca Pharmaceuticals LP $20.00 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105531614 AstraZeneca Pharmaceuticals LP $18.51 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118233492 Boehringer Ingelheim Pharmaceuticals, Inc. $17.29 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118233494 Boehringer Ingelheim Pharmaceuticals, Inc. $17.52 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125335815 Abbott Laboratories $21.39 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131587654 PFIZER INC. $31.36 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131593457 PFIZER INC. $28.51 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131866111 PFIZER INC. $24.13 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132260003 SCPHARMACEUTICALS INC. $22.13 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141652085 Merck Sharp & Dohme LLC $24.37 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141923484 Merck Sharp & Dohme LLC $16.48 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.